We found no correlation between the expression levels of various PRRs (i.e., FPR1, TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR8, TLR9, TLR10, NOD1, NOD2, NALP1, NALP2, NALP3, RIG1, MDA5) and clinical features of NSCLC patients (data available on http://www.cbioportal.org (accessed on 4 January 2021)). This evidence concerns the gene TLR3 and non-small cell lung carcinoma.